| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
assess maternal and fetal outcome of women and newborns who received
chemotherapy during pregnancy to treat Hodgkin lymphoma (HL)in early
stages (IA, IIA), we performed a retrospective analysis of a cohort of
44 pregnant women with HL and early stages, diagnosed and treated
between 1988 to 2013, at a tertiary reference cancer center.
Material and Methods
|Table 1. Mothers. Clinical characteristics.|
|Table 2. Newborns. Clinical characteristics|